Medical Xpress January 24, 2025
New research emphasizes the need for ongoing COVID-19 protection for people with weakened immune systems, with scalable tests helping identify those most at risk to enable tailored strategies.
The research, published in The Lancet, and involving experts from the University of Nottingham and Nottingham University Hospitals NHS Trust reveals how a simple blood test can predict the severity of COVID-19 infection, paving the way for personalized approaches to vaccination and better protection for those most at risk.
The MELODY Study (Mass Evaluation of Lateral Flow Immunoassays for the Detection of SARS-CoV-2 Antibody in Immunosuppressed People) explored how well at-risk individuals develop antibodies after at least three COVID-19 vaccinations. Antibodies are crucial for the body to fight off infection, but patients...
Today's Sponsors
Today's Sponsor